Among vertebrate species of the major vertebrate classes in the wild, a seasonal rhythm of whole body fuel metabolism, oscillating from a lean to obese condition, is a common biological phenomenon. This annual cycle is driven in part by annual changes in the circadian dopaminergic signalling at the suprachiasmatic nuclei (SCN), with diminution of circadian peak dopaminergic activity at the SCN facilitating development of the seasonal obese insulin-resistant condition. The present study investigated whether such an ancient circadian dopamine-SCN activity system for expression of the seasonal obese, insulin-resistant phenotype may be operative in animals made obese amd insulin resistant by high-fat feeding and, if so, whether reinstatement of the circadian dopaminergic peak at the SCN would be sufficient to reverse the adverse metabolic impact of the high-fat diet without any alteration of caloric intake. First, we identified the supramammillary nucleus as a novel site providing the majority of dopaminergic neuronal input to the SCN. We further identified dopamine D2 receptors within the peri-SCN region as being functional in mediating SCN responsiveness to local dopamine. In lean, insulin-sensitive rats, the peak in the circadian rhythm of dopamine release at the peri-SCN coincided with the daily peak in SCN electrophysiological responsiveness to local dopamine administration. However, in rats made obese and insulin resistant by high-fat diet (HFD) feeding, these coincident circadian peak activities were both markedly attenuated or abolished. Reinstatement of the circadian peak in dopamine level at the peri-SCN by its appropriate circadian-timed daily microinjection to this area (but not outside this circadian time-interval) abrogated the obese, insulin-resistant condition without altering the consumption of the HFD. These findings suggest that the circadian peak of dopaminergic activity at the peri-SCN/SCN is a key modulator of metabolism and the responsiveness to adverse metabolic consequences of HFD consumption.
| INTRODUCTION
In the wild, vertebrate species, from teleosts to mammals, exhibit marked annual cycles of metabolism, oscillating between obese and lean conditions during particular seasons of the year. The seasonal obese condition is coupled with the hyperinsulinaemic, insulin-resistant state similar to the human metabolic syndrome. 1, 2 This obese insulinresistant state imparts a survival advantage to the animal during an ensuing/existing season of low/no food (particularly glucose) availability. The available evidence suggests that, under such circumstances, insulin resistance facilitates increased endogenous glucose production to fuel central nervous system metabolism at the same time as the peripheral tissues increase their utilisation of stored fat. 1,2 Importantly, among the seasonal species studied, the shift from the obese, insulinresistant state to the lean, insulin-sensitive condition does not require a change in photoperiod and can occur without any change in food consumption. . 5 At the same time as seasonal animals transition from the insulin-sensitive, glucose tolerant state to the insulin-resistant, glucose intolerant state, when maintained on the same daily photoperiod, there is a marked two-thirds reduction in the circadian peak dopaminergic input activity at the area of the SCN. 5 Moreover, specific lesion of these SCN-area dopaminergic neurones in seasonally lean, insulin-sensitive animals results in the obese insulin-resistant state that cannot be explained by any change in food consumption. 6 It is suggested that the phase relationship between these two (dopaminergic and serotonergic) circadian neural oscillation input signals to the SCN regulates (circadian) output activities from the clock that modulate physiological status based upon their effect to synchronise the phase relationships of multiple peripheral circadian stimulus (eg, insulin) and response (eg, hepatic lipogenic responsiveness to insulin) rhythms. 1, 2 Relevant to these findings are the independent observations of tyrosine-hydroxylase immunopositive (TH+) fibres observed in the SCN area (within the structure and around its perimeter) of perinatal rodents including Syrian hamsters,
Siberian hamsters and rats that diminish in density (although they are still present) within the SCN but are still relatively prominent in the peri-SCN region of the adult. [11] [12] [13] [14] [15] [16] [17] [18] The peri-SCN TH+ fibres were also dopamine β-hydroxylase negative and/or aromatic amino acid decarboxylase positive, suggesting a dopaminergic neuronal function.
11,12
The origin(s) of these TH+ fibres, however, have not been identified and could represent short local (inter)neurones, as well as projections from other anatomical sites, with this being one focus of the present study (see below).
We postulated that this ancient circadian control system for whole body regulation of fuel metabolism may modulate the sensitivity of the body to the obesity/insulin resistance-inducing effects of a high-fat diet (HFD) and, as such, play an important role in regulating the metabolic syndrome-inducing effects of the westernised diet of modern man. This clock system for the regulation of metabolism is sensitive to seasonal changes in nutrient quality (eg, changes in natural flora and fauna cycles) 1 and HFDs have been demonstrated to reduce striatal (mesolimbic) dopamine levels or dopamine receptor availability.
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We therefore postulated that, in animals made obese and insulin resistant by HFD feeding, the circadian peak of dopaminergic input activity to the SCN area would be diminished and also that local SCN restoration of this circadian dopaminergic input activity would be sufficient to reverse the metabolic syndrome-inducing impact of the high fat diet upon metabolism. As such, investigations were undertaken aiming to 0.2 mm from midline and 9.3 mm below the skull). Ten days after FG microinjection, the rats were sacrificed under anesthesia by transcar- tions were first treated with 3% hydrogen peroxide for 10 minutes to quench the endogenous peroxidase activity followed by 1 hour of incubation in animal-free blocker (Vector Laboratories, Burlingame, CA, USA). Then, the sections were immunolabelled at 4°C overnight with a rabbit polyclonal antiserum for FG (dilution 1:3000; AB153; Millipore, Billerica, MA, USA) followed by 1 hour of incubation at room temperature with a goat anti-rabbit biotinylated secondary antiserum (dilution 1:500; Vector Laboratories). The FG immunoreactivity was amplified by an avidin-biotin complex (ABC) system and revealed as dark brown 3,3′-diaminobenzidine (DAB) punctates. Following thorough washing, the sections were re-blocked with animal-free blocker and then sequentially incubated with the mouse monoclonal antiserum for TH (dilution 1:1000; MAB5280; Millipore) at 4°C overnight and a horse anti-mouse biotinylated secondary antiserum (dilution 1:500; Vector Laboratories) for 1 hour at room temperature. Following amplification with the ABC system, the TH immunoreactivities were revealed as diffuse blue-grey staining in the cytoplasm (Vector SG peroxidase substrate kit, SK-4700; Vector Laboratories). The dual-labelled cells were examined under a light microscope (Nikon, Tokyo, Japan). Images were captured by a digital camera and processed using photoshop (Adobe Systems, San Jose, CA, USA).
| In vivo microdialysis
Animals (SD rats) utilised in microdialysis studies were anaesthetised with ketamine/xylazine (80/12 mg kg -1 body weight, i.p.) and mounted on a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA, USA) for implantation of microdialysis probes. In separate studies, a 30-gauge stainless steel guide cannula (CMA Microdialysis, Holliston, MA, USA) was permanently implanted aimed either at the top of the right SCN at coordinates 1.3 mm posterior to bregma, 0.25 right lateral to the midsagittal suture and 8.3 mm ventral to the dura, with the incisor bar set 3 mm below the interaural line or at the top of the ventromedial hypothalamus (VMH) at coordinates 2.6 mm posterior to bregma, 0.6 mm right lateral to the midsagittal suture and 9 mm ventral to the dura.
The guide cannula was anchored firmly to the skull with three stainless-steel screws and cemented in place with dental acrylic.
Animals were allowed 1 week to recover prior to the initiation of microdialysis experimentation. During microdialysis, each animal was placed in an acrylic bowl with free access to food and water.
A 32-gauge dialysis probe with a 1-mm long tip of semi-permeable membrane (20 000 molecular weight cut-off) was inserted into the guide cannula and the probe membrane protruded 1 mm outside the guide cannula into the SCN at 8. Microdialysis samples (0.12 μL min -1 flow rate) were collected into 300-μL vials (containing 2 μL of 0.1 n perchloric acid solution) at hourly intervals through an automated refrigerated fraction collector (modified CMA/170; CMA Microdialysis) over a 24-h period when animals were maintained on a 14 hour daily photoperiod and allowed free access to food and water.
| High-performance liquid chromatography (HPLC) analysis of microdialysis samples
The hypothalamic dialysis samples were analysed by HPLC with electrochemical detection (Coulochem III electrochemical 
| Evaluation of the impact of a HFD on circadian dopamine activities in the SCN and supramammillary nucleus (SuMN) of rats
Female Sprague-Dawley rats (14 weeks of age) were maintained on 14 hour daily photoperiods and allowed to feed and drink ad libitum.
Rats were randomly divided into two groups (N = 10 per group) that were fed either a RC diet or HFD to induce weight gain (25% more than RC fed rats) for 6 weeks. A glucose tolerance test (GTT) was then performed on all rats and then, after a 3-day rest, in vivo microdialysis was used to study daily extracellular profiles of dopamine metabolites in the SCN of rats. Microdialysis samples from the SCN of free-living rats held under a 14 hour daily photoperiod and allowed to feed and drink ad libitum during the sampling were collected every 1 hour con- 
| Dual-label immunohistochemistry of c-Fos and TH
At the end of the above-described microdialysis experiment, HFD and RC fed SD rats were sacrificed under anesthesia by perfusion with PC38; Calbiochem Merck, Darmstadt, Germany) followed by a goat anti-rabbit biotinylated secondary antiserum (dilution 1:500; Vector Laboratories). c-Fos immunoreactivity was revealed as black Ni-DAB punctates in the nucleus. Subsequently, the brain sections were labelled with the mouse monoclonal antiserum for TH (dilution 1:1000; MAB5280; Millipore) followed by a horse anti-mouse biotinylated secondary antiserum (dilution 1:500, Vector Laboratories). TH immunoreactivity was revealed by DAB as brown staining in the cytoplasm. The c-FOS/TH dual-labelled cells were examined under a light microscope (Nikon). The images were captured with a digital camera and processed using photoshop without altering the ratios of signal 
| In vivo electrophysiology recordings
Female SD rats were anaesthetised with thiobutabarbital (120 mg kg or vehicle at the onset of locomotor activity (ZT13), whereas two additional groups of rats received either the same dose of vehicle or dopamine infusion at the same peri-SCN area but at ZT19 as described above. Again, GTTs were performed after 2 weeks of such treatment.
At the end of the experiment, animals were killed and brains were collected and stored at −80°C for neurotransmitter analyses within the VMH and PVN. 
| VMH and PVN NE analysis from animals

| GTT
GTT was performed 6 h after light onset. A 50% glucose solution was administered i.p. (3 g kg -1 body weight) and blood samples were and 120 min after glucose injection for plasma glucose and insulin analyses.
| Assay of metabolic parameters
Blood glucose concentrations were determined by a blood glucose monitor (OneTouch Ultra, LifeScan, Inc.; Milpitas, CA, USA). Plasma insulin and NE were assayed by an enzymeimmunoassay using commercially available assay kits utilising anti-rat serum and rat insulin and NE as standards (ALPCO Diagnostics, Salem, NH, USA). Liver tissue was homogenised in 5% NP-40, heated, centrifuged and supernatant assayed for triglyceride content using a Triglyceride
Determination Kit (catalogue number TR0100; Sigma-Aldrich, St
Louis, MO, USA).
| D1 and D2 dopamine receptor autoradiography
Female SD rats weighing 225-275 g maintained on a LD 14:10 hour After drying at room temperature using an air blower, the slides were stored at −80°C in slide boxes with desiccant. Prior to using the tissue, the section mounted slides were gradually brought to room temperature. For dopamine D2 receptor binding determination, the slides were first equilibrated in Tris-ions assay buffer PrimePCR templates were used to quantify the absolute amount of DRD1, DRD2 and GAPDH mRNA using icycler iq (Bio-Rad). The dopamine D1 and D2 receptor qPCR assays were repeated using a different set of primers, reagents, PCR instrument and software.
RNA was isolated with an Absolutely RNA Miniprep Kit (Agilent) and cDNA was synthesised with an AffinityScript cDNA Synthesis Kit (Agilent). Amplification was conducted with a Brilliant III SYBR green qPCR kit (Agilent) using an AriaMX instrument and analyzed with ariamx software (Agilent).
Primers:
| Statistical analysis
All data are expressed as the mean ± SEM. Statistical analysis were performed using an unpaired Student's t test for two group comparisons or one-way anova for more than two group comparisons, or twoway repeated measures anova for comparisons of treatment groups undergoing repeated measurements at different time points, as appropriate. When the overall anova result was statistically significant, a post-hoc Dunnett's test was carried out to highlight where these differences occur. A statistical value of P < .05 (2-tailed) was considered statistically significant.
| RESULTS
| Neuroanatomical and neurophysiological studies identify dopaminergic neuronal projections from the SuMN to dopamine D2 receptor site regions within the peri-SCN/SCN area
Our previous studies suggested a role for circadian responsiveness to systemic l-DOPA administration in the regulation of seasonal metabolism. [7] [8] [9] [10] Other studies centred on clock region neurophysiology identified a potential cause-effect relationship between a diminution of the circadian peak in dopamine release at the general peri-SCN region and seasonal glucose intolerance. 5, 6 However, the identifica- . Two-way anova with repeated measures on HVA (F) indicates a time effect (F 9,90 = 2.026, P < .05) and also a time and treatment interaction effect (F 9,90 = 3.368, P <0.005). SCN DOPAC (G) is increased in AMPA treated vs vehicle groups (F 1,10 = 5.387, P < .05). There is also a time effect (F 9,90 = 2.509, P < .05) and a time and treatment interaction effect (F 9,90 = 2.065, P < .05)
neurones within the peri-SCN region, thereby aiming to investigate a role for their circadian neurophysiology in the regulation of SCN activity and peripheral metabolism.
Neuroanatomical studies utilised nanolitre injections of the retrograde tracer fluorogold (which labels primary projecting neurone cell bodies when injected at the neuronal terminal region) at the SCN and its perimeter followed by double-immunohistochemical staining with fluorogold and TH (the rate-limiting enzyme in dopamine synthesis) antibodies to trace the origin of primary dopaminergic neurones that project to the peri-SCN (the anatomical area defined as
The high-fat diet (HFD) feeding-induced obese and insulin-resistant condition is accompanied by a concurrent abolishment of the circadian peak in suprachiasmatic nuclei (SCN) dopaminergic activity and of the coincident daily peak in dopaminergic neurone activity in supramammillary nucleus (SuMN) neurones. Animals were fed HFD for 9 weeks and, after 32% of gain in body weight, analyses of SCN area dopamine release and SuMN dopamine activity at different circadian time points were performed. (A) Body weight of regular chow (RC, white bar) and HFD (black bar) fed rats (*P < .0001, HFD fed vs RC fed group) (Student's t test). Plasma glucose (B) and insulin (C) during a glucose tolerance test (*P < .05, difference between the two groups at same time) (anova with repeated measures followed by post-hoc t test). The area under the glucose and insulin tolerance curve in the HFD fed group increased by 23% and 57% respectively, compared to the RC fed group (P < . There is also a time and group interaction effect (F 21,294 = 3.2, P < .0001), which indicates a circadian difference of SCN dopamine activity between the HFD and RC fed groups. Two-way anova with repeated measures on DOPAC (G) reveals a time of day effect (F 21,294 = 5.488, P < .0001) and a time and group interaction effect (F 21,294 = 2.578, P < .0002). All data are expressed as the mean ± SEM (n = 10 per group). (H) The daily peak dopamine neuronal activities at the SuMN and adjacent posterior hypothalamus (PH) were reduced by HFD feeding. The brains from HFD fed obese rats and RC fed lean rats on LD 14:10 h photoperiods were collected during the day (ZT4 [Zeitgeber time] hours after light on set) and night (ZT16), respectively. The activated dopamine neurones were identified as double immune-positive neurones using antibodies against tyrosine hydroxylase (TH) (a rate-limiting enzyme for dopamine synthesis) and c-Fos (neuronal activation marker). The number of activated dopamine neurones at the SuMN/adjacent posterior hypothalamus (determined as number per total sampled areas) in the brains from RC lean rats was 46% higher at ZT16 than at ZT4 (two-way anova analysis: *P < .05; n = 8 or 9) and this circadian peak was abolished in the brains from HFD-fed obese rats (*P < .05). Insert: Number of double positive neurons at each sampled area within the SuMN/PH for animals within each group (mean ± SEM). 
| The circadian peak in SuMN-SCN dopamine release is abolished by HFD feeding
Based upon results of several previous studies demonstrating the import of (i) a circadian rhythm of responsiveness to systemically administered l-DOPA 7-10 and (ii) peri-SCN dopamine activity in the modulation of seasonal metabolism, 5, 6 we postulated that these SuMN-SCN dopaminergic neurones may represent a circadian dopaminergic circuit operative in the modulation of SCN function and its regulation of peripheral metabolism. We further postulated that this circuit may represent not only a clock mechanism regulating seasonal metabolism, but also a biological target for the fattening/insulin resistance-inducing effects of a HFD. Therefore, our next series of studies investigated the potential existence of a daily rhythm of SuMN dopaminergic neuronal activity and a daily rhythm of dopamine release from peri-SCN neurones among lean animals and those made obese/insulin resistant by HFD feeding. Compared to RC fed animals, HFD fed animals had increased body weight (P < .0001, Student's t test) ( Figure 3A) , as well as increased plasma glucose ( Figure 3B ) and insulin ( Figure 3C ) during a GTT (difference between the two groups at same time P < .05, anova with repeated measures followed by a t test). The area under the glucose and insulin GTT curve in the HFD fed group increased by 23% and 57%, respectively, compared to the RC fed group (P < .05, Student's t test). HFD feeding reduced the insulin sensitivity (ie, Belfiore and Matsuda insulin sensitivity indices by 50%
[ Figure 3D ] and 34%, respectively [ Figure 3E ]) (P < . from RC lean rats was 46% higher at ZT16 than at ZT4 (two-way anova analysis: P < .05; n = 8 or 9 per group) and this daily peak is abolished in the brains from HFD fed obese rats ( Figure 3H ), thus corroborating the microdialysis study results reported above.
| The circadian peak in electrophysiological responsiveness to dopamine at the SCN coincides with the circadian peak in dopamine release at the SCN in lean insulin-sensitive rats and is attenuated by HFD feeding
To gain insight into a potential neurophysiological role for the circa- was reduced 50% relative to RC fed controls (two-way anova with repeated measures: F 6,48 = 54.3, P < .0001) ( Figure 4D ).
Consequently, in healthy, non-obese animals, the daily peak of dopamine release at the peri-SCN region is "in-phase" with the 
| Restoration of the circadian peak of dopamine at the SCN of insulin-resistant/glucose intolerant animals held on a HFD attenuates the insulin resistance/glucose intolerance
We next hypothesised that the circadian peak in peri-SCN dopa- relationship between elevated noradrenergic activity at these nuclei and dysmetabolism. 2, 5, [35] [36] [37] Importantly, in the present study, among rats made obese and insulin resistant by HFD feeding, an increased daily level of noradrenergic (extracellular MHPG and NE) and serotonergic (extracellular 5-HIAA) activity at the VMH was observed (38%, 63% and 48%, respectively) (P < .05, P < .005 and P < .05, respectively) F I G U R E 5 Restoring the circadian dopamine peak (Zeitgeber time [ZT]13) at the peri-suprachiasmatic nuclei (SCN) of high-fat diet (HFD) fed, obese insulin-resistant spontaneously hypertensive rats (SHR) rats improves dysmetabolism without affecting food consumption, whereas the same treatment outside this circadian peak window (ZT19) has no effect on insulin resistance of SHR rats. After 6 weeks on HFD, obese animals were treated daily with either vehicle (cerebrospinal fluid) or dopamine (2 nmol) infused at the peri-SCN for 1 min unilaterally at 13 h after light onset (ZT13) for 2 weeks when maintained on the HFD. The following metabolic parameters were assessed after 2 weeks of treatment: (A) body weight at the end of treatment; (B) daily food consumption during the treatment (no difference); (C) retroperitoneal fat pad weight; (D) epididimal fat pad weight; (E) liver triglyceride level; (F) plasma norepinephrine; (G) plasma insulin; and (H) plasma leptin ( † P < .05, 1-tailed t test. (I) Glucose tolerance test (GTT) plasma glucose curves (line graph) and the area under the glucose GTT curve (bar graph). (J) GTT plasma insulin curves (line graph) and the area under the insulin GTT curve (bar graph) and (K) Matsuda and Belfiore insulin sensitivity indices of SHR rats on HFD treated with either vehicle or dopamine at ZT13. Data are expressed as the mean ± SEM (n = 9 per group) (*P < .05 compared to vehicle treatment, unpaired Student's t test). (L-Q) Comparison of metabolic response to peri-SCN dopamine administration at ZT13 vs ZT19. GTT from rats fed HFD for 6 weeks and then receiving dopamine (2 nmol) or vehicle at the onset of locomotor activity (ZT13) or at ZT19 for 2 additional weeks when held on HFD feeding. (L) GTT plasma glucose curves (line graph) and the area under the glucose GTT curve (bar graph), (M) GTT plasma insulin curves (line graph) and the area under the insulin GTT curve (bar graph) and (N) Matsuda and Belfiore insulin sensitivity indices of vehicle (white bar) or dopamine (black bar) peri-SCN treated animals at ZT13. (O) GTT plasma glucose curves (line graph) and the area under the glucose GTT curve (bar graph), (P) GTT plasma insulin curves (line graph) and the area under the insulin GTT curve (bar graph) and (Q) Matsuda and Belfiore insulin sensitivity indices of SHR rats on HFD treated with either vehicle (white bar) or dopamine (black bar) at ZT19. Data are expressed as the mean ± SEM (n = 6 per group) (*P < .05, unpaired Student's t test) (Figure 6 ). Repeated measures anova on NE indicated a group effect (F 1,13 = 14.01, P < .005), as did repeated measures anova on MHPG (F 1,13 = 5.334, P < .05). Repeated measures anova on 5-HIAA also revealed a group effect (F 1,13 = 7.630, P < .05). Following 2 weeks of infusion of dopamine or vehicle into the peri-SCN/SCN region of obese/ insulin-resistant rats at either ZT13 or ZT19 and subsequent to death, brain punches of frozen sections of the hypothalamus were obtained for the analysis of VMH and PVN NE and its metabolites within these study groups. It was found that daily dopamine infusion at the peri-SCN area at ZT13 (the daily peak in dopaminergic activity at this site) but not at ZT19 significantly reduced NE activity (measured as total NE content and NE × NE metabolite product in both the VMH [by 46% and 47%, respectively; P < .05] and the PVN [by 33% and 43%, respectively; P < .05]; unpaired Student's t test) (Figure 7 ).
| DISCUSSION
These studies demonstrate the functionality of a unique, potent and previously unrecognised role for the circadian organisation of dopa- medial hypothalamus, lateral hypothalamus and arcuate nuclei, and also to behavioural/feeding centres in the mesolimbic system. 41, 42, 68, 69 With regard to the present study, the construct of this postulate is that the circadian dopaminergic message at the peri-SCN/SCN area is integrated within the SCN clock system with other local environmental information to modulate SCN output signalling to other downstream metabolic regulatory sites including but not limited to noradrenergic activity at the VMH and PVN activity, each of which in turn regulates peripheral metabolism, in part by adjusting phase relations of numerous metabolic circadian stimulus and response rhythms in target tissues (eg, circadian rhythm of plasma insulin stimulus interacting with a circadian rhythm of hepatic lipogenic responsiveness to insulin).
1-3,61
The present studies suggest that a contributing mediator of this 
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In seasonally obese/insulin-resistant animals, the diminution of the circadian peak of dopaminergic activity at the peri-SCN is coupled with substantial increases in NE release at the VMH. and hepatic inflammatory and gluconeogenic activity, 97 consequently reducing multiple components of insulin resistance syndrome.
It is clear that it is the circadian rhythm of peri-SCN dopaminergic activity and not merely the absolute level of such activity that is critical in manifesting the attenuation of the insulin-resistant/glucose intolerant state because the addition of dopamine to this site at the time of its normal circadian peak in insulin-sensitive/glucose tolerant animals (but not at a time outside this daily) interval manifests this physiological response. It is equally instructive that the impact of the HFD feeding to reduce peri-SCN/SCN dopamine activity was restricted to the circadian peak dopaminergic activity period of the day at this site and showed no such effect during the long low trough activity period of the day (Figure 3) , implicating an impact on a circadian coupling/ expression mechanism and not merely comprising a biochemical inhibitory phenomenon.
Important unanswered questions of the present study include: (i) what is the genesis of these circadian dopamine stimulus and response rhythms at the clock (ie, does the circadian rhythm of SuMN dopamine release at the SCN derive from entrainment by the SCN itself and/or from other sources such as the gut-brain axis?) and (ii) how does HFD feeding reduce the concurrent circadian peaks in SuMN-SCN tyrosine hydroxylase activity and dopamine release, as well as SCN responsiveness to peri-SCN dopamine stimulation? However, the finding of reduced dopaminergic activity is generally consistent with a multitude of studies indicating a reduction of dopamine and/or dopamine receptor levels in other brain areas, particularly the striatal-mesolimbic system, following chronic HFD feeding, although no specific investigation of such feeding on circadian aspects of dopaminergic activity at these brain sites has been investigated. [19] [20] [21] [22] [23] [24] [25] [26] 101, 102 Interestingly, striatal reduction of dopamine levels may partly be the result of reduced gut synthesis of the diet-derived satiety factor, oleoylethanolamine, following HFD feeding, the gastric presentation of which is known to inhibit dopamine efflux in the striatum via vagal inputs. 103 Although attenuation of dopamine function within the mesolimbic system has been associated with a reduction in appropriate reward signalling and consequent overfeeding as a compensatory response to chronic reduced dopaminergic signalling, the presently described circadian dopamine-SCN clock system for regulation of glucose metabolism and body fat appears to be quite a different aspect of CNS dopamine regulation of metabolism in that its influences to attenuate the obese/ insulin-resistant state do not require and are independent of a reduc- Neuroanatomical studies indicate that the major source of the peri-SCN dopamine derives from the SuMN. The SuMN is a hypothalamic nucleus with connections to widespread regions of the hippocampus, forebrain areas, raphe nuclei and limbic system areas. 38 Its role has thus far been defined as an integration centre for cognitive and emotional aspects of behaviour, including reward functions of the nucleus accumbens. 38, 111, 112 The SuMN contributes greatly to theta rhythm generation in the hippocampus 38 dopamine release at the nucleus accumbens leading to overfeeding to achieve reward is concurrent with a diminution of its circadian peak dopamine release at the SCN that facilitates insulin resistance, then these events would synergise to potentiate obesity. Indeed, in preliminary studies, we have observed that attenuation of overall SuMN activity (with GABA agonist, glutamate antagonist cocktail) resulted in overfeeding, obesity and insulin resistance/glucose intolerance within a couple of weeks.
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In conclusion, the present study has identified a previously unrecognised circadian dopaminergic neuronal input modulator system to the biological clock comprised of a circadian rhythm of dopamine release at the peri-SCN area from SuMN neurones and a circadian rhythm of SCN neurone electrophysiological responsiveness to such dopamine release (at the dopamine D2 receptor) for which temporal interaction is coupled with the regulation of peripheral fuel metabolism without inducing a change in daily food consumption. In lean animals, the circadian peaks of these dopaminergic stimulus and response rhythms (are programmed to) coincide, whereas, in animals made obese/insulin resistant by HFD feeding, the daily peaks in these circadian rhythms of both dopamine release and electrophysiologi- 
